CLAY KELLER: Open Payments
NPI 1033133988 · ARGYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 56 payments from 10 companies in 2025. Trend: 2023 $1,018 · 2024 $506 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $258 |
| Otsuka America Pharmaceutical, Inc. | 11 | $221 |
| Indivior Inc. | 9 | $202 |
| Alkermes, Inc. | 9 | $165 |
| Lundbeck LLC | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Braeburn Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $26 |
Products named: REXULTI, CAPLYTA, SUBLOCADE, ARISTADA, FANAPT, COBENFY, Auvelity, VIVITROL.
Industry payments across TX — which companies pay providers there.
